Compounds > n-(3-(dimethylamino)propyl)oleamide
Page last updated: 2024-11-11

n-(3-(dimethylamino)propyl)oleamide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-(3-(dimethylamino)propyl)oleamide: RN given refers to (Z)-isomer; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID6436063
SCHEMBL ID4622859
MeSH IDM0129876

Synonyms (39)

Synonym
9-octadecenamide, n-[3-(dimethylamino)propyl]-, (9z)-
lexamine o 13
oleamide, n-[3-(dimethylamino)propyl]-
tegamine o 13
tegamine 0-13
oleamidopropyl dimethylamine
oleamide, n-[3-(dimethylamino)propyl]-)
oleic acid-n,n-dimethyltrimethylenediamine condensate
109-28-4
n-[3-(dimethylamino)propyl]oleamide
nsc258347
nsc-258347
(z)-n-[3-(dimethylamino)propyl]octadec-9-enamide
nsc 258347
9-octadecenamide, n-(3-(dimethylamino)propyl)-
9-octadecenamide, n-(3-(dimethylamino)propyl)-, (z)-
unii-79k39ju7rn
einecs 203-661-5
n-(3-(dimethylamino)propyl)-9-octadecenamide
9-octadecenamide, n-(3-(dimethylamino)propyl)-, (9z)-
(3-(oleoylamido)propyl)dimethylamine
dimethylaminopropyl oleamide
oleamide, n-(3-(dimethylamino)propyl)-
79k39ju7rn ,
n-(3-(dimethylamino)propyl)oleamide
oleamidopropyl dimethylamine [inci]
schercodine o
oleic acid 3-(n,n-dimethylamino)propylamide
schercodine o amido-amine
unizeen oa
mackine 501
SCHEMBL4622859
oleoylaminopropyl-n,n-dimethylamine
UCWYGNTYSWIDSW-QXMHVHEDSA-N
9-octadecenamide,n-[3-(dimethylamino)propyl]-, (9z)-
DTXSID10873803
n-3-oleylamidopropyl dimethylamine
Q27266762
9-octadecenamide,n-[3-(dimethylamino)propyl]-,(9z)-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19902 (33.33)18.7374
1990's2 (33.33)18.2507
2000's1 (16.67)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.12

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.12 (24.57)
Research Supply Index2.30 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.12)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (33.33%)4.05%
Observational0 (0.00%)0.25%
Other6 (66.67%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
betaine
glycine betaine : The amino acid betaine derived from glycine.		2.4420amino-acid betaine;
glycine derivative		fundamental metabolite
nickel
Nickel: A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.. nickel ion : A nickel atom having a net electric charge.. nickel atom : Chemical element (nickel group element atom) with atomic number 28.		2.0610metal allergen;
nickel group element atom		epitope;
micronutrient
3-dimethylaminopropylamine
3-dimethylaminopropylamine: RN given refers to parent cpd; structure		2.0210
ascaridole
ascaridole: monoterpene endoperoxide with anthelmintic properties; structure given in first source. ascaridole : A p-menthane monoterpenoid that is p-menth-2-ene with a peroxy group across position 1 to 4.		2.0610organic heterobicyclic compound;
organic peroxide;
p-menthane monoterpenoid		antileishmanial agent;
antinematodal drug;
plant metabolite
cocamidopropyl betaine
cocamidopropyl betaine: structure given in first source; Genagen CAB, Tego Betain, Rewoteric AMB 14 usually contain 30% cocamidopropyl betaine (CAPB). cocamidopropyl betaine : A mixture of carboxamidopropyl betaines derived from fatty acids of varying chain lengths. The principal component is lauramidopropyl betaine.. lauramidopropyl betaine : An ammonium betaine in which the the ammonium nitrogen is substituted by two methyl groups and a lauramidopropyl group. It is the major (>50%) component of cocamidopropyl betaine.		2.4420ammonium betainesurfactant
cobalt
Cobalt: A trace element that is a component of vitamin B12. It has the atomic symbol Co, atomic number 27, and atomic weight 58.93. It is used in nuclear weapons, alloys, and pigments. Deficiency in animals leads to anemia; its excess in humans can lead to erythrocytosis.. cobalt(1+) : A monovalent inorganic cation obtained from cobalt.. cobalt atom : A cobalt group element atom that has atomic number 27.		2.0610cobalt group element atom;
metal allergen		micronutrient
citral
citral: Xref geranial: geraniol is also available; Xref neral: nerol is also available; vitamin A antagonist; oxygenated monoterpene; inhibits cytosolic dehydrogenases; structure. citral : An enal that consists of octa-2,6-dienal bearing methyl substituents at positions 3 and 7. A mixture of the two geometric isomers geranial and neral, it is the major constituent (75-85%) of oil of lemon grass, the volatile oil of Cymbopogon citratus, or of C. flexuosus. It also occurs in oils of verbena, lemon, and orange.		2.0610enal;
monoterpenoid;
polyprenal		plant metabolite;
volatile oil component
isoeugenol
trans-isoeugenol : The trans-stereoisomer of isoeugenol.		2.0610isoeugenolplant metabolite
ConditionIndicatedRelationship StrengthStudiesTrials
Allergic Contact Dermatitis
[description not available]		02.7130
Dermatitis, Allergic Contact
A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.		02.7130
Contact Dermatitis
[description not available]		02.6630
Dermatitis, Contact
A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.		02.6630